Daiwa Securities Group Inc. - CORBUS PHARMACEUTICALS HLDGS ownership

CORBUS PHARMACEUTICALS HLDGS's ticker is CRBP and the CUSIP is 21833P103. A total of 103 filers reported holding CORBUS PHARMACEUTICALS HLDGS in Q1 2019. The put-call ratio across all filers is 1.39 and the average weighting 0.3%.

Quarter-by-quarter ownership
Daiwa Securities Group Inc. ownership history of CORBUS PHARMACEUTICALS HLDGS
ValueSharesWeighting
Q3 2020$1,000
-50.0%
4050.0%0.00%
Q2 2020$2,0000.0%4050.0%0.00%
Q1 2020$2,0000.0%4050.0%0.00%
Q4 2019$2,0000.0%4050.0%0.00%
Q3 2019$2,000
-33.3%
4050.0%0.00%
Q2 2019$3,000
+50.0%
405
+33.7%
0.00%
Q1 2019$2,0000.0%3030.0%0.00%
Q4 2018$2,0000.0%3030.0%0.00%
Q3 2018$2,0000.0%3030.0%0.00%
Q2 2018$2,0000.0%3030.0%0.00%
Q1 2018$2,0003030.00%
Other shareholders
CORBUS PHARMACEUTICALS HLDGS shareholders Q1 2019
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 3,738,925$23,555,00031.22%
Perceptive Advisors 1,232,500$7,764,0000.39%
IFP Advisors, Inc 1,001,025$6,306,0000.27%
WOODSTOCK CORP 55,489$350,0000.07%
Virtus ETF Advisers LLC 50,795$320,0000.05%
Dynamic Technology Lab Private Ltd 31,431$198,0000.04%
Evanson Asset Management, LLC 20,660$130,0000.03%
Artal Group S.A. 250,000$1,575,0000.03%
GSA CAPITAL PARTNERS LLP 58,800$370,0000.02%
Raymond James Financial Services Advisors, Inc. 426,280$2,686,0000.02%
View complete list of CORBUS PHARMACEUTICALS HLDGS shareholders